banner2

Getting started
Lesinurad CAS 878672-00-5

Lesinurad CAS 878672-00-5 - China Manufacturers, Factory, Suppliers

Lesinurad CAS 878672-00-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

CAS 1533519-85-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Lesinurad Intermediate CAS 1533519-85-5 Purity >99.0% (HPLC)
Read More

Lesinurad CAS 878672-00-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Lesinurad (RDEA 594) CAS 878672-00-5 Purity >99.5% (HPLC) Assay 98.0~102.0%

Lesinurad Intermediate CAS 1533519-84-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Lesinurad Intermediate CAS 1533519-84-4 Purity >99.0% (HPLC)

Lesinurad Intermediate CAS 1533519-92-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 4-Cyclopropylnaphthalen-1-Amine Hydrochloride CAS 1533519-92-4 Lesinurad Intermediate Purity >99.0% (HPLC)

Lesinurad (RDEA 594) CAS 878672-00-5 Purity >99.5% (HPLC) Assay 98.0~102.0%

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

banner1

Top Selling Products

Related Blog
Reviews

Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...

2022.11.21 07:22:40
2022.11.06 15:11:22
2022.10.31 04:53:43
2022.09.23 06:06:04
2022.09.02 01:44:16
2021.12.25 17:25:49

related search